Skip to Main Content (Press Enter)

×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca

UNIFIND

|

UNIFIND

unisr.it

×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca

Pubblicazioni

JOURNAL OF CLINICAL ONCOLOGY

Rivista

Codice:

E091050

ISSN:

0732-183X

Dati Generali

Dati Generali

Pubblicazioni (162)

Ordina Pubblicazioni:

ascendente
decrescente

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer

Articolo

A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer

Abstract

A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

Abstract

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer after Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial

Articolo

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Articolo

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Articolo

Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors

Articolo

Acute oxaliplatin-induced thrombotic thrombocytopenic purpura: A case report and results from a cytoflourimetric assay of platelet fibrinogen receptor

Articolo

Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Articolo

Alternative schedules of adjuvant temozolomide in glioblastoma multiforme: A 6-year experience.

Articolo

Ascend: Phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia

Articolo

Assessment of tocilizumab in the treatment of cancer cachexia

Articolo

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options-An Analysis From the Global Germ Cell Cancer Group

Articolo

Breast cancer subtypes and outcome after local and regional relapse

Abstract

Can Rituximab Change the Usually Dismal Prognosis of Patients With Intravascular Large B-Cell Lymphoma?

Articolo

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

Articolo

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

Articolo

Characterization of innate responses elicited by neoadjuvant radio-chemotherapy for rectal cancer

Abstract

Chemo-endocrine versus endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors

Articolo

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Articolo

Chlamydia psittaci (Cp)-eradicating therapy with doxycycline is an active treatment against ocular adnexa MALT lymphoma (OAML): Final results of a multicentre prospective trial.

Abstract

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Articolo

Cisplatin-Based Chemotherapy and the Risk of Solid Tumors in Patients With Testicular Nonseminoma: Still a Matter of Debate

Articolo

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer

Articolo

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Articolo

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-helicobacter pylori therapy

Articolo

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes

Articolo

Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation

Articolo

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era

Articolo

Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC)

Articolo

Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer

Articolo

Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database

Articolo

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study

Articolo

Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting

Articolo

Definitive results of a phase II trial of cisplatin epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma

Articolo

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi

Articolo

Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?

Articolo

Dose escalation in salvage radiation therapy and urinary toxicity: A small price to pay for a significant prospective benefit

Articolo

Early immune reconstitution and abrogation of GvHD after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation.

Articolo

Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies

Articolo

Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Articolo

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

Articolo

Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321) (Journal of Clinical Oncology (2025) DOI: 10.1200/JCO-25-00166)

Articolo

F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy

Abstract

FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression

Articolo

Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)

Abstract

Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)

Articolo

Final results of a phase III trial of gemcitabine (G) versus PEFG regimen in stage IVA or metastatic pancreatic adenocarcinoma (PA)

Abstract

Final results of a randomized, phase III study of rituximab with or without idelalisib followed by open-label idelalisib in patients with relapsed chronic lymphocytic leukemia

Articolo

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

Articolo

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer

Articolo

First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC)

Articolo

First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia

Articolo

Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms

Articolo

Genomic characterization of early-stage asymptomatic lung cancers

Articolo

Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model

Articolo

Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial

Articolo

Graft-versus-tumor effect following reduced-intensity allogeneic stem cell transplantation in prostate cancer.

Articolo

HER2-Low breast cancer: Pathological and clinical landscape

Articolo

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer

Articolo

Healthcare provider experiences in managing antibody-drug conjugate dosing adjustments due to nausea and vomiting: SABCS and ESMO survey findings

Abstract

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

Articolo

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater

Articolo

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Articolo

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

Articolo

Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer

Articolo

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine: A Pan-European study

Articolo

Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma

Articolo

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

Articolo

Improving the Prognostic Ability for Personalized Therapeutic Approaches in Nonseminomatous Germ Cell Tumors

Articolo

In reply

Articolo

Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: An answer for few

Articolo

Induction chemotherapy plus concomitant oxaliplatin-based chemoradiotherapy for locally advanced rectal cancer: A real world experience at San Raffaele Hospital

Abstract

Infusions of HSV-TK genetically modified donor lymphocytes enable a wider use of partially mismatched allogeneic transplantation by reducing infection related mortality and improving survival in high risk acute leukemia.

Abstract

Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer

Articolo

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

Articolo

Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas?

Articolo

Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial

Articolo

Long-Term Remission of HIV-Associated Primary CNS Lymphoma Achieved With Highly Active Antiretroviral Therapy Alone

Articolo

Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting

Abstract

Long-term safety and survival outcomes after TK-expressing donor lymphocyte infusion (TK-DLI) in allogeneic hematopoietic stem cell transplantation (HSCT)

Abstract

Low dose spiral computed tomography for early diagnosis of lung cancer. Results of baseline screening in 5,000 high-risk volunteers

Articolo

Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot-blot analysis

Articolo

Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma

Articolo

Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative intent surgical resection

Articolo

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study

Articolo

Mechanism of thymic renewal after infusion of suicide gene-modified donor T cells after hematopoietic stem cell transplantation (HSCT) in adult patients

Abstract

Mechanisms of thymic renewal after Infusion of suicide gene-modified donor T cellsafter hematopoietic stem cell transplantation (HSCT) in adult patients

Poster

Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression

Articolo

MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior

Articolo

Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare

Articolo

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers

Articolo

Morbidity and mortality after surgical treatment of screening detected lung cancer

Articolo

Mortality for non-AIDS-defining cancers among people with AIDS

Articolo

Multi-institutional validation of a new renal cancer-specific survival nomogram

Articolo

Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma

Articolo

Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma

Articolo

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Articolo

Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?

Articolo

Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy

Articolo

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Articolo

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Articolo

Outcome of men with relapses after adjuvant bleomycin, etoposide, and cisplatin for clinical stage I nonseminoma

Articolo

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Articolo

Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway

Articolo

Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study

Articolo

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor α, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

Articolo

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Articolo

Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

Abstract

Postoperative nomogram for predicting survival after resection for intrahepatic cholangiocarcinoma

Articolo

Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium

Articolo

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

Articolo

Preoperative hyperfractionated radiotherapy (HFRT) and concomitant chemotherapy (CT) in locally advanced primary rectal cancer (LA-PRC) in elderly patients

Abstract

Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group

Articolo

Primary CNS lymphomas prognosis

Articolo

Primary tumor cells show specific susceptibility to KIR-incompatible NK-cell mediated lysis in an ex-vivo single cell cytotoxic assay (SCCA).

Articolo

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from trial BIG 1-98 comparing adjuvant endocrine therapy with tamoxifen versus letrozole

Articolo

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal women with early breast cancer: results from study BIG 1-98

Articolo

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy

Articolo

Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience

Articolo

Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC)

Contributo in Atti di convegno

Proof of Activity of Anti-Epidermal Growth Factor Receptor-Targeted Therapy for Relapsed Squamous Cell Carcinoma of the Penis

Articolo

Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution

Articolo

Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial

Articolo

Raltitrexed-eloxatin (TOM OX) salvage chemotherapy (CHT) in gemcitabine (GEM) resistant metastatic pancreatic cancer (PC): a phase II trial

Abstract

Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Articolo

Randomized phase II trial of budesonide versus placebo in high-risk population with screening-detected lung nodules: Update on secondary endpoints

Articolo

Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses

Abstract

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.

Articolo

Randomized phase III trial of haploidentical HCT with or without an add back strategy of HSV-TK donor lymphocytes in patients with high-risk acute leukemia

Abstract

Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain

Articolo

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Articolo

Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy

Articolo

Reply to A. Korfel et al

Articolo

Reply to CG Rusthoven et al

Articolo

Reply to M. Valerio et al

Articolo

Reply to S. Zhang

Articolo

Resected pancreatic cancer: A proposal for a prognostic score

Abstract

Resected pancreatic cancer: A proposal for a prognostic score

Articolo

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

Articolo

Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients

Articolo

Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study

Abstract

Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: A multicenter Gruppo Italiano Terapie Innnovative nei Linfomi survey

Articolo

Salvage Radiation Therapy for Increasing Prostate-Specific Antigen After Radical Prostatectomy: Who, When, and How?

Articolo

Salvage radiation therapy for biochemical recurrence after radical prostatectomy: Is earlier always better?

Articolo

Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group)

Abstract

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Articolo

Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium

Articolo

The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis: A multi-institutional analysis

Articolo

The in vivo targeting of tumor antigens to DCs by administration of transduced autologous lymphocytes results in robust and prolonged immunization: Preclinical validation and results of a pilot clinical studies of vaccination for metastatic melanoma.

Articolo

The role of androgen response pathway in association with tumor biology and response to neoadjuvant immune-checkpoint inhibitors (ICI) in muscle-invasive urothelial bladder carcinoma (MIBC)

Articolo

Thymic renewal and antileukemic effect in adults after haploidentical transplantation and suicide gene therapy

Poster

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Articolo

Trends in incidence and survival of early-stage pancreatic ductal adenocarcinoma in the United States

Abstract

Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab

Articolo

Type 1 gastric carcinoids: Efficacy and safety of endoscopic management

Articolo

Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass

Articolo

Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A prospective study

Articolo

Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials

Articolo

Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?

Articolo

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

Articolo

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/ TP53 Mutation: SEQUOIA Arm D Results

Articolo

No Results Found

«
‹

{pageNumber}

›
»

{startItem} - {endItem} di {itemsNumber}

Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0